pancreatic cancer

Pancreatic Cancer Update: Abandoned Trial, Exciting Research, New Appointments
BioSpace
Tue, 07/2/19 - 11:52 pm
pancreatic cancer
Boston Biomedical
Cold Spring Harbor Laboratory
PanCan
Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo test
Fierce Biotech
Tue, 07/2/19 - 10:30 am
Boston Biomedical
clinical trials
pancreatic cancer
napabucasin
How a long-known biomarker backs BioNTech's antibody for pancreatic cancer
Fierce Biotech
Thu, 06/20/19 - 07:56 pm
BioNTech
pancreatic cancer
CA19-9
biomarkers
Early cancer drug data give Amgen hope it's 'cracked KRAS code'
Biopharma Dive
Mon, 06/3/19 - 11:30 am
ASCO 2019
KRAS
lung cancer
colorectal cancer
pancreatic cancer
Amgen
AMG 510
ASCO 2019 day three
Pharmaforum
Sun, 06/2/19 - 01:09 pm
ASCO 2019
Merck
AstraZeneca
pancreatic cancer
Novartis
alpelisib
Roche
entrectinib
Breakthrough in Pancreatic Cancer Research Could Lead to New Treatments
BioSpace
Fri, 05/3/19 - 10:34 pm
pancreatic cancer
genes
R&D
Early pancreatic cancer data give Clovis a new path in PARP market
Biopharma Dive
Tue, 04/2/19 - 04:22 pm
pancreatic cancer
Clovis Oncology
AstraZeneca
PARP inhibitors
AACR
Rubraca
Lynparza
Despite research boom, few immunotherapy studies targeting pancreatic cancer
Biopharma Dive
Mon, 04/1/19 - 12:18 pm
pancreatic cancer
cancer immunotherapy
AACR
Bristol-Myers Squibb
Merck
Apexigen
Apexigen's CD40 agonist shows response in pancreatic cancer
BioCentury
Mon, 04/1/19 - 10:41 am
Apexigen
APX005M
Opdivo
pancreatic cancer
Celgene’s Abraxane Fails to Hit the Mark in a Phase III Pancreatic Cancer Study
BioSpace
Wed, 03/13/19 - 12:17 pm
Celgene
Abraxane
clinical trials
pancreatic cancer
AstraZeneca, Merck notch another major Lynparza trial win — this time in pancreatic cancer
Endpoints
Tue, 02/26/19 - 09:34 am
AstraZeneca
Merck
pancreatic cancer
clinical trials
BRCA-mutated prostate cancer
Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Fierce Pharma
Mon, 01/21/19 - 10:54 am
AbbVie
JNJ
Imbruvica
pancreatic cancer
clinical trials
The Demise Of A Once Promising Pancreatic Cancer Drug Is All Too Common
Forbes
Tue, 01/15/19 - 10:01 am
pancreatic cancer
drug development
Harvard
GSK pancreatic cancer drug heads to phase 1 combo with Merck's Keytruda after positive mouse trial
Fierce Biotech
Mon, 11/12/18 - 11:47 pm
GSK
GSK095
Merck
Keytruda
pancreatic cancer
New Study Suggests Tumor Treating Fields Can Increase Progression-Free Survival in Pancreatic Cancer
CP Wire
Mon, 10/22/18 - 10:09 am
Novocure
pancreatic cancer
New Study Suggests Tumor Treating Fields Can Increase Progression-Free Survival in Pancreatic Cancer
Mon, 10/22/18 - 09:47 am
Novocure
pancreatic cancer
AstraZeneca, Merck’s Lynparza gets FDA ODD for pancreatic cancer
Pharmaceutical Business Review
Wed, 10/17/18 - 09:11 am
AstraZeneca
Merck
Lynparza
FDA
pancreatic cancer
orphan drug
Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors
CP Wire
Thu, 07/12/18 - 09:17 am
Seattle Genetics
colorectal cancer
non-small cell lung cancer
pancreatic cancer
head and neck cancer
cervical cancer
tisotumab vedotin
Genmab
clinical trials
Pancreatic cancer study failure cripples a Merrimack drug, forcing a coup de grâce and pipeline retreat
Endpoints
Mon, 06/25/18 - 09:24 am
pancreatic cancer
MM-141
Merrimack Pharmaceuticals
Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection
CP Wire
Wed, 05/23/18 - 10:30 pm
pancreatic cancer
diagnostics
biomarkers

Pages